186.71MMarket Cap-1768P/E (TTM)
4.600High3.610Low17.98MVolume3.800Open3.010Pre Close72.21MTurnover43.25%Turnover RatioLossP/E (Static)48.88MShares26.35052wk High1.07P/B158.78MFloat Cap1.76052wk Low--Dividend TTM41.57MShs Float26.350Historical High--Div YieldTTM32.89%Amplitude0.590Historical Low4.017Avg Price1Lot Size
Cabaletta Bio Stock Forum
📊⚡️📊
📊⚡️📊
Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024
Cabaletta Bio (Nasdaq: CABA) announced two presentations at the upcoming American College of Rheumatology (ACR) Convergence 2024, featuring new and updated clinical data on CABA-201, their 4-1BB-containing fully human CD19-CAR T cell investigational therapy. The presentations will cover:
1. An oral presentation on the safety and efficacy of C...
No comment yet